Keros Therapeutics Inc (KROS)
60.35
-2.72
(-4.31%)
USD |
NASDAQ |
Nov 14, 16:00
60.35
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics Profit Margin (Quarterly): -13.65K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -13.65K% |
| June 30, 2024 | -122.3K% |
| March 31, 2024 | -51.94K% |
| December 31, 2023 | -28.14K% |
| September 30, 2023 | -493.0K% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -34.70% |
| Date | Value |
|---|---|
| September 30, 2021 | |
| June 30, 2021 | -15.62K% |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -110.0% |
| September 30, 2019 | -142.0% |
| June 30, 2019 | -114.1% |
| March 31, 2019 | -127.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-493.0K%
Minimum
Sep 2023
-34.70%
Maximum
Dec 2021
-90.60K%
Average
-21.88K%
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Regeneron Pharmaceuticals Inc | 36.03% |
| Scholar Rock Holding Corp | -- |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.60% |
| Return on Assets | -40.96% |
| Return on Invested Capital | -44.60% |
| Operating Margin (Quarterly) | -15.12K% |
| Return on Net Operating Assets | -456.8% |